Portola Announces Pricing of Public Offering of Common

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Portola Announces Pricing of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., March 10, 2015 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. (Nasdaq: PTLA ) announced today the pricing of its underwritten public offering of 2,495,652 shares of its common stock at a price to the public of $40.00 per share. In addition, the underwriters of the offering have been granted a 30-day option to purchase up to an additional 374,348 shares from Portola at the public offering price. The offering is expected to close on March 13, 2015, subject to customary closing conditions.

Morgan Stanley and Credit Suisse are acting as the joint book-running managers for the offering. Cowen and Company and Sanford C. Bernstein are acting as co-managers. A preliminary prospectus supplement and final prospectus supplement may be obtained from the offices of Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014, or by email at prospectus@morganstanley.com or Credit Suisse Securities (USA) LLC, Attention: Prospectus Department, One Madison Avenue, New York, NY 10010, by email at newyork.prospectus@credit-suisse.com or by toll-free call to (800) 221-1037.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission and became effective on October 1, 2014. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Portola Pharmaceuticals, Inc.

Portola Pharmaceuticals is a biopharmaceutical company developing product candidates that could significantly advance the fields of thrombosis and other hematologic diseases. The Company is advancing its three wholly-owned programs using novel biomarker and genetic approaches that may increase the likelihood of clinical, regulatory and commercial success of its potentially life-saving therapies. Portola's partnered program is focused on developing selective Syk inhibitors for inflammatory conditions.

Forward-Looking Statements

This announcement contains forward-looking statements, including statements relating to Portola Pharmaceuticals' expectations regarding the completion of the proposed public offering. These statements are subject to significant risks and uncertainties and actual results could differ materially from those projected. Portola Pharmaceuticals cautions investors not to place undue reliance on the forward-looking statements contained in this release. These risks and uncertainties include, without limitation, risks and uncertainties related to market conditions and satisfaction of customary closing conditions related to the public offering. There can be no assurance that Portola Pharmaceuticals will be able to complete the public offering on the anticipated terms, or at all. Risks and uncertainties relating to Portola Pharmaceuticals and its business can be found in the "Risk Factors" section of Portola Pharmaceuticals' Form 10-K for the year ended December 31, 2014 filed with the SEC on March 2, 2015, and in the prospectus supplement related to the offering filed with the SEC. Portola Pharmaceuticals undertakes no duty or obligation to update any forward-looking statements contained in this release as a result of new information, future events or changes in Portola Pharmaceuticals' expectations.

Media: Joey Fleury, BrewLife, , 415.946.1090 Investors: Alexandra Santos, Portola Pharmaceuticals, , 650.246.7239

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Kinross Gold Fraud Lawsuit: What Shareholders Need to Know

Updated Category News Views 64

Kinross Gold's Legal Quagmire There's a fresh storm brewing for Kinross Gold Corporation (NYSE: KGC), and it ain't the kind investors enjoy riding. You see, the company is up to its neck in a class action lawsuit, courtesy of Schall, Brown & Schwartz LLP—a big-name shareholder rights litigation outfit. The gripe? Alleged securities fraud, violating §§10(b) and 20(a)...

Continue Reading
Animal Parasite Market Growth Has a Resistance Catch

Updated Category News Views 41

Flea collars and cattle worms do not sound glamorous, yet this is exactly where durable animal-health revenue gets built. Wissen Research puts the global animal parasiticides market at $13.6 billion in 2026 and projects $18.6 billion by 2031, a 6.5% compound annual growth rate. That is respectable, not moonshot stuff, and frankly that is part of the appeal. Pet owners...

Continue Reading
Stand Out For Good Makes a Bold Michigan Avenue Bet

Updated Category News Views 51

A six-floor retail commitment lands with a thud Stand Out For Good is taking on roughly 51,079 square feet at 669 North Michigan Avenue, and nobody should mistake that for a casual expansion. Six levels on Chicago's Magnificent Mile is a proper declaration of intent, especially in a retail district that has endured plenty of empty-window handwringing and big-brand churn....

Continue Reading
Stand Takes Colorado Bet on Wildfire-Smart Coverage

Updated Category News Views 21

Colorado’s insurance mess has finally attracted a company willing to price the driveway, the vents, and the tree line instead of shrugging at an entire ZIP code. Stand has launched homeowners coverage across the state, including mountain communities where wildfire exposure has made insurance both costly and scarce. This is not a small problem dressed up with a shiny...

Continue Reading
Vertiv's 800 VDC Push Gives AI Builders More Choices

Updated Category News Views 192

Electricity is becoming the awkward roommate inside every serious AI buildout, and Vertiv is trying to move it out of the rack before it eats the whole house. The company has expanded its 800 VDC offering beyond the PowerDirect 5000 rack product introduced in May 2026, laying out systems for the rack, the AI compute pod, and the full data hall. For investors following...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 152

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading
OFRM Faces Legal Heat Over Toddler Snack Recall

Updated Category News Views 200

OFRM Under the Microscope: Who Saw This Coming? Smack dab in the middle of navigating everyday market volatility, here's Once Upon A Farm (NYSE: OFRM) taking the spotlight—but for all the wrong reasons. The company got slapped with a stark FDA warning. Their Tractor Wheels toddler snacks allegedly pose a choking risk— think 'dry, sticky mass' refusing to budge with...

Continue Reading
Amdocs Faces a Storm: Investor Alert as Legal Probe Begins

Updated Category News Views 64

Amdocs' Recent Crisis: What Investors Need to Know Lately, it seems Amdocs Limited (NASDAQ: DOX) has found itself knee-deep in a situation that could make seasoned investors cringe. November shone some harsh light on the company's operations, a move that’s attracted attention from Schall, Brown & Schwartz LLP (“SBS”), a name not exactly foreign to shareholder...

Continue Reading
Wall Street Gains Hold Amid Volatility Drop

Updated Category News Views 66

A Week of Gains and Regulatory Moves Right out of the gate, it’s been a decent stretch for Wall Street. Weekly gains kept the party going, even as traders navigated the usual hurdles. Stocks finished the week with a solid performance—all the heavy hitters like Dow, S&P 500, Nasdaq, and Russell 2000 ended on a high note, waltzing uphill past where many imagined...

Continue Reading
TYYY Liquidation Leaves Holders With a Tight Exit Window

Updated Category News Views 79

A fund can vanish faster than investors can read the fine print, and TYYY is doing exactly that. Exchange Traded Concepts has approved the closure and liquidation of the xETFs TSLA Daily Income ETF, with the fund expected to cease operations and distribute cash on or about November 20, 2026. This is not a debate about whether holders should love or hate Tesla. The product...

Continue Reading

Top 5 Most Recently Viewed Articles

Brooge Energy Shareholders Take Action Against Ernst & Young

Updated Category News Views 408

Investors Initiate Legal Action Against Ernst & Young In a significant development for Brooge Energy, some shareholders have lodged a fraud complaint against Ernst & Young in the United States. They accuse the auditor of failing to uncover significant discrepancies in the oil storage firm's financial reports over two years. The Allegations Explained The shareholders...

Continue Reading
Trakka Systems Shows Off ISR Tech at Farnborough Airshow

Updated Category News Views 28

Trakka Systems Steals the Spotlight at Farnborough Trakka Systems, that familiar name in the critical vision game, is about to make some noise at the Farnborough International Airshow 2026 in the UK. Yep, they're rolling out live shindigs of their top-tier tech, and if you're near Stand C322, you won't want to miss it. It's all happening July 20–24, and you bet they're...

Continue Reading
Market Trends: Fastenal's Earnings and Stock Movements Today

Updated Category News Views 167

Stock Market Overview The U.S. stock market faced slight declines today, with the Dow Jones index dipping by approximately 0.1%. Following the opening of the market, the Dow decreased by 0.09%, settling at 44,330.95. Similarly, the NASDAQ fell by 0.09% to reach 20,566.69, while the S&P 500 experienced a minor decline of 0.17%, now standing at 6,249.07. Market Sector...

Continue Reading
Market Fluctuations: Traders Target Opportunities in Crypto Stocks

Updated Category News Views 264

Bitcoin's Impact on Crypto Stocks The recent drop in Bitcoin below $80,000 significantly affected crypto-related stocks, leading to declines in major companies like Coinbase Global Inc (COIN), Robinhood Markets Inc (HOOD), MARA Holdings Inc (MARA), and Riot Platforms Inc (RIOT). This downturn raised questions among traders about potential buying opportunities as the...

Continue Reading
Class Action Alert: PepGen Inc. Faces Securities Law Issues

Updated Category News Views 148

PepGen Inc. and the Class Action Lawsuit PepGen Inc. is currently embroiled in a class action lawsuit, and shareholders who have invested in the company might want to take note of their rights. This situation arose from allegations that the firm violated securities laws, leading to detrimental impacts for its investors. Shareholders are encouraged to understand the...

Continue Reading